I'm not anti-margin except for new investors. I don't mess with it. But then I hate interest payments and avoid those whenever I can, too. lol. If people are experienced in trading and know how the market works, then I don't have problems with it. But again, that's just me.
What do you mean by "latest market news"? Like what kind of news? I pretty much don't limit myself to anything, tbh -- anything can be a news source. I use cnbc.com, marketwatch.com, benzinga, etc. Only thing I don't like about CNBC now is some of their good stuff is going behind a paywall (CNBC Pro). A lot of the news I also get can come from within TDAmeritrade's newsfeeds which point to any of a number of sources.
Been getting killed with nvax. Should've sold when it was one of the few games in town but got suckered into articles singing praises of worldwide contracts. I'm not really sure. I'll have to reply back when I understand it better. Banks are bidding and buying Tbills at near 0%, so something weird is going on. https://www.bloomberg.com/news/arti...treasury-bill-auction-yield-as-supply-shrinks
this is in concert w the Fed's stated goal of keeping the interest @ zero. thus, in this scenario, the difference in rates, TBills vs, 10-yr, is the de facto real inflation
$RTPZ supposedly gonna announce their target is Hippo tmrw. I have my sell limit order ready to dump all my shares. Ever since LMND crapped their earnings, nobody wants to touch insurance.
@adoo to put into context, BMO analyst when he had $97 price target, had FY21 $115m in software rev, $80m in drug discover rev, which seemed conservative since BMY deal was for $2.7bn over 4 years, with 55m upfront. SDGR gave FY21 guidance for $102-$110m software rev and $22-$32m drug discover rev. Sorry for hyping this. The discovery rev may be backlogged to future years; but no hiding that it's a bad guidance. Want to hear what they say on the conf call, but not optimistic. edit: pretty sad conf call. only silver lining is that they have no debt and $640m cash, at current $5bn cap, with their pipeline of in-house drugs there's some value there. if it drops to low $60s i may buy more.... but for now devastated and need to regroup. i think i need a break.
the silver lining on this move is that, thank goodness, my loss is capped at $2.35 sold another bullish put spread, apr expiraton bto 75 put, sto 80 put, collecting a premium of $2.65, defining my max risk of $2.35
geez! 73??? Did not see that coming. Brother in law got in at 100 and got out 110. Lucky fool. This is why I stay away from earnings play. Wayyy too much of a gamble.
i bought most of my position between $65-$70 in november. wasn't expecting such a big miss. all the analyst projections were way off. shouldn't have sold those puts ytd. i'm 50% cash now. if u guys have good ideas where to deploy i'm all ears. otherwise i'll just wait on the sidelines. lost most of my 2021 gains.
this 20+% dip would make SDGR an attractive buyout candidate for googl / amzn ? or another Cathy Wood pick out ?
That's for the quick recap. No need to hold my shares for a quick bounce. I did not expect such a big gap down and it blew past my stop limit but it is what it is. Thankfully my RTPZ sell limit got filled in pre-market.
to everyone that bought cos of my enthu, big sorries. in the low $60s i will (quietly) look at avg in again. i think there's enough evidence that the tech works. it's a virtual monopoly in a disruptive emerging space, but projections got way ahead of the take up. the sense i get is the software is "easy" to use, in that it's kind of like photoshop with good UI, but to get good results it requires a PHD in chemistry, and one that's focused on the theoretical side. take up is slower than i thought it would be. CTHR is at price of insider buying atm if anyone has any appetite left haha. https://www.sec.gov/edgar/search/?r...20COLVARD%20LTD%20(CTHR)%20(CIK%200001015155)
No sweat. It was still a green trade for me and there were plenty of signals to get in back then and I appreciated all your thoughts. Hard to predict gap ups/downs that large but it's part of the game.
It depends if you think this is the tail end OR the beginning of a market correction. ; ) AAPL has been trading in a range between 120-140 since November but I dumped it because the bull trend looks like it broke around 3-4 weeks ago similar to NASDAQ so I'm going to sit on the sidelines until I see a trend reversal but the main catalyst I'm looking for is the release of IOS 14.5.
no sweat, i appreciate your suggestion/ideas. i m ~ 70 -75% cash. will spent the next couple of wks to finish my tax return for 2020; as a general practice, i m on the sideline until a couple days after the tax deadline of ~ 15 April. while on the sideline, will also be monitoring these CRM, APPS, WFC,MS, LPX, AAPL (been sitting on the lower trading channel, then start shopping.
at this stage i'm happy if i can get not tanking, and a slow and steady upward trend lol. i get the re-opening rotation and "value" thinking; but a lot of these reopening plays have already run up, and after factoring growth, googl/aapl/msft look like better value to me on a fwd earnings basis. one concern with googl is aapl's move to diminish their ad power with their "privacy" moves, not sure how big of an impact that will be. can't make $ if not vested either.
